Pilot scorecard
MaryRuth Organics scored 4 out of 6 for label disclosure under methodology v1.13, read from the label as captured on 2026-09-27.
60ct variant, Amazon listing B08T6N3DKY.
The single active carries an exact amount, Bacillus subtilis (DE111) 8.33 mg (2.5 Billion CFU). No proprietary blend on the panel.
No standardization-dependent ingredient in the formula.
DE111 is a strain designation, not the species alone.
No positive-outcome human trial for DE111 at a gastrointestinal outcome was identified on 2026-09-27, and no paediatric trial of the strain was identified at any dose, which is the population this product is sold for. The two DE111 trials that measured gut endpoints both reported no effect (Freedman 2021 PMID 33671071; Townsend 2018 PMID 30049931), and under the positive-outcome-trials-only rule a null trial does not set a range. The reference table row records the full search per the negative-findings rule. Note the label itself is not the problem here: it discloses the dose in both mg and CFU and names the strain, so a buyer could check it if the evidence existed to check it against. The failure is in the evidence base, and the objection recorded under v1.11 applies with full force to this row.
No publicly accessible third-party certificate of analysis located 2026-09-27 (listing images, maryruthorganics.com including the quality page, site-scoped and open web search). The listing and site display Clean Label Project Purity Award and B Corp certification marks, which are certifications rather than product certificates of analysis and are excluded on the same basis as GMP marks. Recorded as a negative finding, not a claim that none exists.
Serving size 1 gummy and servings per container 60 are both printed on the panel.
Scores are read from the live label, captured by screenshot on the date shown. A score describes what the label discloses. It says nothing about whether the product works, and nothing here was lab-tested.
